Skip to content
10-K

Annual Report

Vilacto Bio Inc.

0001663577-19-000301

← back to feed
Filed
Jul 10, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Jun 19, 2019 1.92B sh
Operating Cash Flow FY 2019 · Mar 31, 2019 −$601.15K
Operating Cash Flow FY 2019 · Mar 31, 2018 −$338.01K
Cash And Equivalents FY 2019 · Mar 31, 2019 $257.22K
Cash And Equivalents FY 2019 · Mar 31, 2018 $148.77K
Cash And Equivalents FY 2019 · Mar 31, 2017 $22.02K
Stockholders Equity FY 2019 · Mar 31, 2019 −$3.42M
Stockholders Equity FY 2019 · Mar 31, 2018 −$935.91K
Stockholders Equity FY 2019 · Mar 31, 2017 −$42.8K
Current Liabilities FY 2019 · Mar 31, 2019 $3.96M
Current Liabilities FY 2019 · Mar 31, 2018 $1.25M
Total Liabilities FY 2019 · Mar 31, 2019 $3.96M
Total Liabilities FY 2019 · Mar 31, 2018 $1.25M
Current Assets FY 2019 · Mar 31, 2019 $376.29K
Current Assets FY 2019 · Mar 31, 2018 $308.87K
Total Assets FY 2019 · Mar 31, 2019 $537.67K
Total Assets FY 2019 · Mar 31, 2018 $309.77K
Sga Expense FY 2019 · Mar 31, 2019 $299.78K
Sga Expense FY 2019 · Mar 31, 2018 $109.26K
Net Income FY 2019 · Mar 31, 2019 −$7.86M
Net Income FY 2019 · Mar 31, 2018 −$893.12K
Operating Income FY 2019 · Mar 31, 2019 −$970.04K
Operating Income FY 2019 · Mar 31, 2018 −$381.55K
Gross Profit FY 2019 · Mar 31, 2019 $851
Gross Profit FY 2019 · Mar 31, 2018 $846
Cost Of Revenue FY 2019 · Mar 31, 2019 $4.04K
Cost Of Revenue FY 2019 · Mar 31, 2018 $583
Revenue FY 2019 · Mar 31, 2019 $4.89K
Revenue FY 2019 · Mar 31, 2018 $1.43K